Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-27
pubmed:abstractText
Interferon gamma release assays (IGRAs) offer alternatives to tuberculin skin tests (TSTs) for diagnosing latent tuberculosis infection (LTBI). Unlike TSTs, IGRAs require only a single patient visit and are not affected by prior BCG vaccination, providing greater specificity. Of 2 Food and Drug Administration-approved IGRAs, the newer QuantiFERON-TB Gold in Tube test (QFT-GIT) requires less manual processing time than the QuantiFERON-TB Gold test (QFT-G). We compared the cost-effectiveness of the QFT-G, QFT-GIT, and TST for detecting LTBI in new health care workers (HCWs).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1538-3679
pubmed:author
pubmed:issnType
Electronic
pubmed:day
26
pubmed:volume
169
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
179-87
pubmed:dateRevised
2009-7-29
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
pubmed:affiliation
Division of Infectious Diseases, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Box 670560, Cincinnati, OH 45267, USA. deperiom@hotmail.com
pubmed:publicationType
Journal Article, Comparative Study